1. Home
  2. NTRA vs DOV Comparison

NTRA vs DOV Comparison

Compare NTRA & DOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • DOV
  • Stock Information
  • Founded
  • NTRA 2003
  • DOV 1947
  • Country
  • NTRA United States
  • DOV United States
  • Employees
  • NTRA N/A
  • DOV N/A
  • Industry
  • NTRA Medical Specialities
  • DOV Industrial Machinery/Components
  • Sector
  • NTRA Health Care
  • DOV Industrials
  • Exchange
  • NTRA Nasdaq
  • DOV Nasdaq
  • Market Cap
  • NTRA 24.9B
  • DOV 23.0B
  • IPO Year
  • NTRA 2015
  • DOV N/A
  • Fundamental
  • Price
  • NTRA $173.27
  • DOV $163.39
  • Analyst Decision
  • NTRA Strong Buy
  • DOV Buy
  • Analyst Count
  • NTRA 17
  • DOV 12
  • Target Price
  • NTRA $192.41
  • DOV $212.42
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • DOV 952.5K
  • Earning Date
  • NTRA 11-11-2025
  • DOV 10-23-2025
  • Dividend Yield
  • NTRA N/A
  • DOV 1.25%
  • EPS Growth
  • NTRA N/A
  • DOV 54.81
  • EPS
  • NTRA N/A
  • DOV 16.59
  • Revenue
  • NTRA $1,964,250,000.00
  • DOV $7,829,059,000.00
  • Revenue This Year
  • NTRA $24.28
  • DOV $5.86
  • Revenue Next Year
  • NTRA $15.22
  • DOV $5.24
  • P/E Ratio
  • NTRA N/A
  • DOV $9.93
  • Revenue Growth
  • NTRA 44.38
  • DOV 1.73
  • 52 Week Low
  • NTRA $117.27
  • DOV $143.04
  • 52 Week High
  • NTRA $183.00
  • DOV $222.31
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 59.76
  • DOV 30.66
  • Support Level
  • NTRA $157.43
  • DOV $164.62
  • Resistance Level
  • NTRA $173.62
  • DOV $168.32
  • Average True Range (ATR)
  • NTRA 5.35
  • DOV 2.54
  • MACD
  • NTRA 0.04
  • DOV -0.13
  • Stochastic Oscillator
  • NTRA 67.61
  • DOV 4.42

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About DOV Dover Corporation

Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.

Share on Social Networks: